| |
Latest 10 SEC filings (by transaction date) for PDSB within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 23/24 | Jan 22/24 | Shepard Kirk V. | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 200,000 | |
Dec 4/23 | Dec 4/23 | Boesgaard Lars | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 200,000 | |
Jul 17/23 | Jul 14/23 | Freitag Gregory Gene | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Brawley Otis W | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Ali-Jackson Kamil | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Sykes Richard | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Glover Stephen C. | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Iliev Ilian | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PDSB within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 23/24 | Jan 22/24 | Shepard Kirk V. | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 200,000 | |
Dec 4/23 | Dec 4/23 | Boesgaard Lars | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 200,000 | |
Jul 17/23 | Jul 14/23 | Freitag Gregory Gene | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Brawley Otis W | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Ali-Jackson Kamil | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Sykes Richard | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Glover Stephen C. | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Jul 17/23 | Jul 14/23 | Iliev Ilian | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 9,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |